Spectral Medical Inc.
EDTXF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -17% | 42.1% | -11.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $1 | $0 | $0 |
| % Margin | 71.7% | 64.2% | 78.1% | 57.5% |
| R&D Expenses | $0 | $2 | $0 | $0 |
| G&A Expenses | $3 | $3 | $4 | $3 |
| SG&A Expenses | $3 | $3 | $4 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | -$2 | $0 | $0 |
| Operating Expenses | $4 | $3 | $4 | $3 |
| Operating Income | -$3 | -$2 | -$4 | -$3 |
| % Margin | -464.3% | -306.9% | -619.1% | -394.3% |
| Other Income/Exp. Net | -$27 | $1 | -$9 | $6 |
| Pre-Tax Income | -$30 | -$2 | -$13 | $3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$30 | -$2 | -$13 | $3 |
| % Margin | -4,491.3% | -237.8% | -2,203.7% | 489% |
| EPS | -0.11 | -0.007 | -0.044 | 0.011 |
| % Growth | -1,517.6% | 84.7% | -492% | – |
| EPS Diluted | -0.11 | -0.007 | -0.044 | 0.011 |
| Weighted Avg Shares Out | 287 | 285 | 285 | 280 |
| Weighted Avg Shares Out Dil | 287 | 285 | 285 | 280 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$29 | -$1 | -$11 | $4 |
| % Margin | -4,279% | -86.2% | -2,003.3% | 654% |